Number of WT-1– or NY-ESO-1–specific CTLs
| . | WT-1(WT126) . | NY-ESO1 (NY157) . |
|---|---|---|
| Control | 0.023/1 | 0.558/1 |
| IL-21 | 0.413/17.96 | 5.144/9.21 |
| CD25 depletion | 0.203/8.83 | 5.144/9.21 |
| CD25 depletion + IL-21 | 5.928/257.74 | 56.78/101.76 |
| . | WT-1(WT126) . | NY-ESO1 (NY157) . |
|---|---|---|
| Control | 0.023/1 | 0.558/1 |
| IL-21 | 0.413/17.96 | 5.144/9.21 |
| CD25 depletion | 0.203/8.83 | 5.144/9.21 |
| CD25 depletion + IL-21 | 5.928/257.74 | 56.78/101.76 |
The increase in absolute number of WT-1– or NY-ESO-1–specific CTLs as well as the fold increase in numbers compared with control cultures are shown.